We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Walmart Deepens Healthcare Reach With Medicare Support Push
Read MoreHide Full Article
Key Takeaways
Walmart launched a nationwide effort to help Medicare users understand prescription drug coverage.
The program offers pharmacist consultations, digital tools and links to healthcare resources.
Walmart's pharmacy scale and health focus could drive engagement and loyalty over time.
Walmart Inc. (WMT - Free Report) and Sam’s Club have launched a nationwide initiative to help Medicare beneficiaries better understand prescription drug coverage options for weight management and other chronic conditions. While the program is primarily educational, it could strengthen Walmart’s healthcare presence by increasing pharmacy engagement and deepening customer loyalty while potentially supporting prescription volumes over time.
The initiative will provide educational materials, pharmacist consultations, digital navigation tools and assistance connecting customers with healthcare resources. With nearly 5,000 pharmacy locations, including stores in rural and underserved communities, Walmart is well-positioned to help seniors navigate evolving Medicare coverage requirements.
The move aligns with Walmart’s broader focus on weight management and chronic care. The company has been expanding support for customers using or exploring GLP-1 therapies through its Better Care Services platform, complemented by nutrition resources, wellness products and pharmacy services.
Walmart’s first-quarter fiscal 2027 earnings call highlighted the growing importance of its health and wellness business. The company reported continued prescription volume growth, pharmacy market share gains, investments in digital healthcare capabilities and faster pharmacy delivery options, underscoring its efforts to improve healthcare accessibility and convenience.
While the initiative is not expected to have a significant impact on earnings in the near term, it could benefit Walmart over time by bringing more customers to its pharmacies, creating opportunities for additional health and wellness purchases and strengthening its reputation as a trusted healthcare destination. Overall, the move fits Walmart’s strategy of leveraging its physical scale, digital tools and pharmacy network to build stronger customer relationships beyond traditional retail.
Walmart currently carries a Zacks Rank #3 (Hold). Shares of the company have risen 19.6% over the past year compared with the industry’s growth of 16.7%.
WMT Price Performance Versus Industry
Image Source: Zacks Investment Research
From a valuation standpoint, WMT trades at a forward price-to-earnings ratio of 38.6, higher than the industry’s average of 35.02.
WMT Valuation Compared to Industry
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for WMT’s current and next fiscal-year earnings per share implies year-over-year growth of 9.5% and 13.3%, respectively.
Stocks to Consider
Ross Stores, Inc. (ROST - Free Report) , a leading U.S. off-price retailer operating Ross Dress for Less and dd's DISCOUNTS stores, sports a Zacks Rank #1 (Strong Buy) at present. ROST delivered a trailing four-quarter earnings surprise of 10.2%, on average. You can see the complete list of today’s Zacks #1 Rank stocks here.
The consensus estimate for Ross Stores’ current fiscal-year sales and earnings suggests growth of 9.1% and 17.1%, respectively, from the year-ago figures.
Dollar Tree, Inc. (DLTR - Free Report) , a leading discount retailer, currently carries a Zacks Rank #2 (Buy). DLTR delivered a trailing four-quarter earnings surprise of 32.1%, on average.
The Zacks Consensus Estimate for Dollar Tree’s current fiscal-year sales and earnings implies growth of 6.5% and 21.4%, respectively, from the year-ago figures.
The TJX Companies, Inc. (TJX - Free Report) , a major off-price apparel and home fashions retailer, currently carries a Zacks Rank #2.
The Zacks Consensus Estimate for The TJX Companies’ current fiscal-year sales calls for growth of 5.9%, and estimates for earnings suggest a 9.3% increase from the year-ago figure. TJX delivered a trailing four-quarter earnings surprise of 8.8%, on average.
View the Zacks #1 Rank List
Image: Bigstock
Walmart Deepens Healthcare Reach With Medicare Support Push
Key Takeaways
Walmart Inc. (WMT - Free Report) and Sam’s Club have launched a nationwide initiative to help Medicare beneficiaries better understand prescription drug coverage options for weight management and other chronic conditions. While the program is primarily educational, it could strengthen Walmart’s healthcare presence by increasing pharmacy engagement and deepening customer loyalty while potentially supporting prescription volumes over time.
The initiative will provide educational materials, pharmacist consultations, digital navigation tools and assistance connecting customers with healthcare resources. With nearly 5,000 pharmacy locations, including stores in rural and underserved communities, Walmart is well-positioned to help seniors navigate evolving Medicare coverage requirements.
The move aligns with Walmart’s broader focus on weight management and chronic care. The company has been expanding support for customers using or exploring GLP-1 therapies through its Better Care Services platform, complemented by nutrition resources, wellness products and pharmacy services.
Walmart’s first-quarter fiscal 2027 earnings call highlighted the growing importance of its health and wellness business. The company reported continued prescription volume growth, pharmacy market share gains, investments in digital healthcare capabilities and faster pharmacy delivery options, underscoring its efforts to improve healthcare accessibility and convenience.
While the initiative is not expected to have a significant impact on earnings in the near term, it could benefit Walmart over time by bringing more customers to its pharmacies, creating opportunities for additional health and wellness purchases and strengthening its reputation as a trusted healthcare destination. Overall, the move fits Walmart’s strategy of leveraging its physical scale, digital tools and pharmacy network to build stronger customer relationships beyond traditional retail.
WMT Stock Price Performance, Valuation & Estimates
Walmart currently carries a Zacks Rank #3 (Hold). Shares of the company have risen 19.6% over the past year compared with the industry’s growth of 16.7%.
WMT Price Performance Versus Industry
Image Source: Zacks Investment Research
From a valuation standpoint, WMT trades at a forward price-to-earnings ratio of 38.6, higher than the industry’s average of 35.02.
WMT Valuation Compared to Industry
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for WMT’s current and next fiscal-year earnings per share implies year-over-year growth of 9.5% and 13.3%, respectively.
Stocks to Consider
Ross Stores, Inc. (ROST - Free Report) , a leading U.S. off-price retailer operating Ross Dress for Less and dd's DISCOUNTS stores, sports a Zacks Rank #1 (Strong Buy) at present. ROST delivered a trailing four-quarter earnings surprise of 10.2%, on average. You can see the complete list of today’s Zacks #1 Rank stocks here.
The consensus estimate for Ross Stores’ current fiscal-year sales and earnings suggests growth of 9.1% and 17.1%, respectively, from the year-ago figures.
Dollar Tree, Inc. (DLTR - Free Report) , a leading discount retailer, currently carries a Zacks Rank #2 (Buy). DLTR delivered a trailing four-quarter earnings surprise of 32.1%, on average.
The Zacks Consensus Estimate for Dollar Tree’s current fiscal-year sales and earnings implies growth of 6.5% and 21.4%, respectively, from the year-ago figures.
The TJX Companies, Inc. (TJX - Free Report) , a major off-price apparel and home fashions retailer, currently carries a Zacks Rank #2.
The Zacks Consensus Estimate for The TJX Companies’ current fiscal-year sales calls for growth of 5.9%, and estimates for earnings suggest a 9.3% increase from the year-ago figure. TJX delivered a trailing four-quarter earnings surprise of 8.8%, on average.